Qube Research & Technologies (QRT)
BCYC

Qube Research & Technologies (QRT)’s Bicycle Therapeutics BCYC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.29M Buy
775,567
+466,950
+151% +$2.14M ﹤0.01% 1850
2026
Q1 		$1.43M Buy
+308,617
New +$1.76M ﹤0.01% 2343
2022
Q3 		– Sell
-124,696
Closed -$2.09M – 2513
2022
Q2 		$2.09M Buy
124,696
+115,890
+1,316% +$2.44M 0.02% 786
2022
Q1 		$386K Buy
+8,806
New +$411K ﹤0.01% 1653

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BCYC Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Bicycle Therapeutics (BCYC) stake by 151% in Q2 2026, buying an estimated $2.14M and bringing the position to 775,567 shares worth $3.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1850.

Qube Research & Technologies (QRT) first reported a position in BCYC in Q1 2022 and has held it in 4 quarters since. 104 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • Qube Research & Technologies (QRT) held 775,567 shares of Bicycle Therapeutics worth $3.29M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 466,950 Bicycle Therapeutics shares in Q2 2026, an estimated $2.14M.
  • Bicycle Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1850 holding.
  • Qube Research & Technologies (QRT) first reported a position in Bicycle Therapeutics in Q1 2022 and has held it in 4 quarters since.
  • 104 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.